A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

BACKGROUND: Docetaxel plus cisplatin and 5-fluorouracil has become a new standard for treating advanced gastric cancer. However, high rates of severe neutropenia limit its application. Modification of the regimen could be the solution to get similar activity but less myelosuppression. METHODS: Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, C-P, Chen, J-S, Chen, L-T, Yen, C-J, Lee, K-D, Su, W-P, Lin, P-C, Lu, C-H, Tsai, H-J, Chao, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990611/
https://www.ncbi.nlm.nih.gov/pubmed/20924378
http://dx.doi.org/10.1038/sj.bjc.6605928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990611/
https://www.ncbi.nlm.nih.gov/pubmed/20924378
http://dx.doi.org/10.1038/sj.bjc.6605928

Ejemplares similares